BUSINESS
Granules India surges as its arm clears audit by US health regulator
Granules India is currently trading at Rs. 380.75, up by 12.75 points or 3.46% from its previous closing of Rs. 368.00 on the BSE. The scrip opened at…
Granules India is currently trading at Rs. 380.75, up by 12.75 points or 3.46% from its previous closing of Rs. 368.00 on the BSE. The scrip opened at…
The National Financial Reporting Authority (NFRA) has issued the Audit Quality Review Report (AQRR) of the Statutory Audit for the year 2017-18 of…
The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada,…